Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A reveal strong financial performance with raised earnings outlook, robust growth in key segments like Aerospace & Electronics, and strategic M&A activities. Despite some uncertainties in chemical markets, positive trends in nonchemical sectors and defense, along with effective margin management, support a positive sentiment. The raised guidance and strategic initiatives outweigh concerns, suggesting a positive stock price movement.
Adjusted EPS $1.64, driven by an impressive 5.6% core sales growth, primarily reflecting broad-based strength at Aerospace & Electronics and continued strong execution at Process Flow Technologies.
Core Sales Growth 5.6%, driven primarily by the ongoing strength within Aerospace & Electronics.
Adjusted Operating Profit Increased 19%, driven by continued strong net price and solid productivity.
Core FX-neutral Backlog Up 16% compared to last year, reflecting continued strength at Aerospace & Electronics.
Core FX-neutral Orders Up 2% compared to last year.
Aerospace & Electronics Sales $270 million, increased 13% in the quarter, nearly all of that organic growth.
Aerospace & Electronics Backlog Just over $1 billion, up 27% year-over-year.
Aerospace & Electronics Core Orders Up 5%.
Total Aftermarket Sales Increased 20% with commercial aftermarket up 23% and military aftermarket up 12%.
OEM Sales Increased 10% in the quarter with both commercial and military up 10%.
Adjusted Segment Margin for Aerospace & Electronics 25.1%, expanded 160 basis points from 23.5% last year, primarily reflecting strong net price, solid productivity and the impact from the higher volumes.
Process Flow Technologies Sales $319 million, up 3% with flat core performance in the quarter, along with a 1.6% benefit from the Technifab acquisition and 1.5 points of favorable foreign exchange.
Process Flow Technologies Core FX-neutral Backlog Decreased 5% compared to last year.
Process Flow Technologies Core FX-neutral Orders Down slightly as expected.
Adjusted Operating Margin for Process Flow Technologies 22.4%, expanded 60 basis points higher than last year, driven by strong productivity, mix and net price inclusive of tariff headwinds in the quarter.
200-kilowatt traction motor inverter generator controller: Launched at the AUSA trade show in October, aimed at defense vehicle OEMs for programs like the Common Tactical Truck and new combat vehicle programs.
SyFlo wastewater pump: Introduced at WEFTEC, featuring advanced non-clog and pellet technology with leading efficiency metrics. Shipments began in Q3.
Aerospace & Electronics: Strong backlog and new program wins provide visibility into 2026 and beyond. Growth driven by Boeing and Airbus production ramp-ups and elevated aftermarket activity.
Process Flow Technologies: Stable end markets with strength in wastewater, pharmaceuticals, cryogenics, and power. Chemical markets remain soft but stable.
Core sales growth: Achieved 5.6% growth in Q3, driven by Aerospace & Electronics.
Adjusted operating profit: Increased by 19%, supported by strong net pricing and productivity.
Backlog: Core FX-neutral backlog up 16% year-over-year, driven by Aerospace & Electronics.
Acquisition of Precision Sensors & Instrumentation (PSI): On track to close by year-end. Integration planning is progressing smoothly, expected to be accretive to margins and growth.
M&A pipeline: Active with opportunities in Aerospace & Electronics and Process Flow Technologies, with deal sizes ranging from $100 million to $500 million.
Tariff Impacts: The company expects gross cost increases of roughly $30 million for the year due to Section 232 tariffs. While they plan to offset these impacts through price and productivity, this remains a dynamic area that could pose challenges.
Chemical Market Conditions: The chemical markets remain soft, which could impact growth in the Process Flow Technologies segment. However, the company is focusing on targeted opportunities tied to preventative maintenance and technology upgrades.
Integration of PSI Acquisition: While the integration planning for the pending acquisition of Precision Sensors & Instrumentation (PSI) is progressing smoothly, there is always a risk of unforeseen challenges during the integration process that could impact strategic execution.
Commercial Aftermarket Deceleration: The company anticipates decelerating year-over-year growth rates in the commercial aftermarket in Q4, which could impact overall performance in the Aerospace & Electronics segment.
Defense Market Fragmentation: Over the past two years, customer vehicle development efforts in the defense market were fragmented with numerous concepts in play and uncertainty around government funding. Although this has improved, it remains a potential risk area.
Economic and Market Uncertainty: The company acknowledges a dynamic macroeconomic backdrop and heightened global uncertainty, which could impact operations and strategic objectives.
Full Year Adjusted Earnings Outlook: The company has raised and narrowed its full-year adjusted earnings outlook to a range of $5.75 to $5.95, reflecting 20% adjusted EPS growth at the midpoint compared to 2024.
2026 Organic Growth Assumptions: The company expects 4% to 6% organic growth in 2026, leveraging on average of 35%.
Pending Acquisition of Precision Sensors & Instrumentation (PSI): The acquisition is on track to close by January 1, 2026. PSI is expected to be accretive to financial profiles, including margins and growth, within the next few years.
Aerospace & Electronics Segment Outlook: The backlog and new program wins provide strong visibility into 2026 and beyond. Core sales growth for 2025 is anticipated to be up low double digits, with growth leveraged at 35% to 40% for the full year. The segment is expected to outperform its markets over the next decade.
Process Flow Technologies Segment Outlook: Core growth for 2025 is expected to fall at the lower end of the low to mid-single-digit growth range, with greater margin expansion as core volumes leverage at the higher end of the targeted range for the full year.
Defense and Aerospace Market Trends: The company anticipates growth from new emerging opportunities, including scaling and upgrades of radar, counter unmanned aerial systems, high-power energy, and space-based assets. The defense market is expected to benefit from government funding priorities and increased demand drivers.
Municipal Wastewater Pump Business: The business is on track for double-digit growth in 2025, driven by strong momentum in new product adoption.
Cryogenic Business: The business secured double-digit growth in new orders in Q3 2025, with continued growth expected in aerospace, defense, space launch, satellite production, and semiconductor investments.
Pharmaceutical Orders: The company won a $6 million large pharmaceutical order supporting capacity expansion for GLP-1 drug manufacturing, positioning it for future growth in this space.
The selected topic was not discussed during the call.
The earnings call summary presents a mixed picture: basic financial performance is stable with some positive elements like increased interest checking balances, but noninterest income is flat. The Q&A reveals potential for modest loan growth and deposit cost improvements, but also highlights uncertainties in M&A and future tax rates. The strategic plan outlines raised earnings outlook and growth potential in various segments, yet lacks a strong catalyst for a significant stock price change. Thus, the overall sentiment leans towards neutral, with no major factors indicating a strong price movement.
The earnings call presents a positive outlook with raised earnings guidance, strong growth in aerospace, and new acquisitions expected to enhance margins. The Q&A reinforces this with opportunities in pricing and acquisitions, while integration costs are managed. The company's strategic focus on expanding technology and market segments further supports a positive sentiment. Despite some uncertainty in specific financial targets, the overall positive guidance and growth prospects outweigh these concerns, suggesting a likely stock price increase.
The earnings call summary and Q&A reveal strong financial performance with raised earnings outlook, robust growth in key segments like Aerospace & Electronics, and strategic M&A activities. Despite some uncertainties in chemical markets, positive trends in nonchemical sectors and defense, along with effective margin management, support a positive sentiment. The raised guidance and strategic initiatives outweigh concerns, suggesting a positive stock price movement.
The earnings call presents a mixed picture. Strong core sales and order growth in Aerospace & Electronics, along with a robust M&A pipeline, are positive indicators. However, concerns about declining margins in A&E, cautious management outlook, and unclear guidance on cash EPS and margin expansion for PSI offset these positives. The Q&A section highlights management's cautious stance and lack of specificity in certain areas, leading to a neutral sentiment overall.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.